Mindfulness Walking Intervention to Enhance Resilience (iWalk)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-110
SponsorUniversity of Illinois at Urbana-Champaign
About this trial
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS).
The objectives are to evaluate:
1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years or older,
clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
never received meditation training via coaching/certification/life coaching,
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
iWalk Program
BehavioralA multi-component behavioral program integrating walking meditation, education, and group sessions to enhance resilience and stress regulation in adults with and without chronic conditions.
Treatment groups
90 Participants
are divided into 3 treatment groupsGroup A: iWalk ProgramActive comparator 1 intervention
Group B: Education Only without Walking Mindfulness PracticeActive comparator 1 intervention
Group C: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Connor Davidson Resilience Scale for Adults (CD-RISC 25)
Time frame
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.2
Multiple Sclerosis Resilience Scale (MSRS)
Time frame
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.3
Stroop Task
Time frame
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.4
Symbol Digit Modalities Test
Time frame
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov